The University of Texas Medical Branch · 12 hours ago
Research Associate III (Basic Science & Transitional Research - Galveston)
The University of Texas Medical Branch is a leading institution in health research, and they are seeking a Research Associate III to assist with various research assignments and experiments. The role involves supporting Principal Investigators in protocol development and conducting preclinical studies related to imaging components of sheep studies.
Responsibilities
Assisting with protocol development, related to the imaging components of sheep studies
Assisting with the acquisition and analysis of images collected at different stages of in vivo studies to assess tissue/female reproductive system responses to various interventions and drug delivery approaches
Establishing imaging tools to evaluate tissue morphology and to quantify imaging-derived data enabling non-invasive assessment of drug-induced tissue toxicity
Providing support during the conduct of preclinical studies and assist with the development and implementation of assays aimed at assessing tissue responses to therapeutic or preventive interventions
Qualification
Required
Bachelor's degree in basic science or equivalent and 5 years of related experience or Master's degree in basic science or equivalent and 3 years of related experience required
Company
The University of Texas Medical Branch
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas
H1B Sponsorship
The University of Texas Medical Branch has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (73)
2024 (66)
2023 (52)
2022 (57)
2021 (49)
2020 (50)
Funding
Current Stage
Late StageTotal Funding
$35MKey Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M
Recent News
2025-10-30
Quetzal Therapeutics
2025-09-17
EIN Presswire
2025-08-25
Company data provided by crunchbase